A Closer Look at…Genetic Medicine and Artificial Intelligence

A Closer Look

An episode of the Stem Cell Channel (Video) podcast, hosted by UCTV: UC San Diego, titled "A Closer Look at…Genetic Medicine and Artificial Intelligence" was published on August 19, 2025 and runs 57 minutes.

August 19, 2025 ·57m · Stem Cell Channel (Video)

0:00 / 0:00

Summary

AI and genetic medicine are converging to transform how we diagnose, treat, and prevent disease. Gene Yeo, Ph.D., unites RNA biology with artificial intelligence to speed the path from genome sequencing to personalized RNA therapeutics. Advances in sequencing have reduced costs dramatically, making interpretation and translation into treatments the real challenge. Using deep learning and large datasets of RNA-binding proteins, Yeo predicts disease vulnerabilities and identifies therapeutic targets, including in neurodegeneration and muscular diseases. Alexis Komor, Ph.D., focuses on DNA, explaining human genetic variation—particularly single-nucleotide variants—and how genome editing technologies like CRISPR can target them. She highlights strategies to correct harmful mutations and explores precise, programmable interventions. Together, their research drives discovery and enables more effective, personalized therapies. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40459]

Episode Description

AI and genetic medicine are converging to transform how we diagnose, treat, and prevent disease. Gene Yeo, Ph.D., unites RNA biology with artificial intelligence to speed the path from genome sequencing to personalized RNA therapeutics. Advances in sequencing have reduced costs dramatically, making interpretation and translation into treatments the real challenge. Using deep learning and large datasets of RNA-binding proteins, Yeo predicts disease vulnerabilities and identifies therapeutic targets, including in neurodegeneration and muscular diseases. Alexis Komor, Ph.D., focuses on DNA, explaining human genetic variation—particularly single-nucleotide variants—and how genome editing technologies like CRISPR can target them. She highlights strategies to correct harmful mutations and explores precise, programmable interventions. Together, their research drives discovery and enables more effective, personalized therapies. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40459]

Share this episode

Similar Episodes

Research for the end of Autism Action Month

Apr 28, 2024 ·14m

Little Brains Answer Big Questions

Oct 14, 2023 ·34m

The earliest differences across ASDs

Jul 17, 2022 ·23m

Families work hard for treatments

Jun 1, 2020 ·13m

Oops the media did it again…

Apr 10, 2017

Exploiting genetics to understand environmental risks for autism

Mar 14, 2017

Similar Podcasts

Stem Cell Channel (Audio) UCTV Stem cell science is changing medicine and our understanding of human development. The Stem Cell Channel takes you into the labs where cutting edge-research takes place, introduces you to the scientists leading the way, and breaks down how these amazing discoveries impact everyday life and health. Stem Cell Exchanges Cambridge University Podcast series with principal investigators of the Cambridge Stem Cell Institute, supported by the institute's Public Engagement Seed Fund, in collaboration with Pint of Science. Mariana Alves (Silva Group) has been interviewing a selection of our SCI Principal Investigators for a series of 11 podcasts. The podcasts seek to uncover each group leaders approach to research and the impact their discoveries are having on our understanding of stem cells and disease.This podcast series will be followed up by an event in Cambridge in June 2017 where we showcase artworks inspired by the research of all the scientists we interview, for more information please go on http://www.stemcells.cam.ac.uk/public/currentprojects/exchanges-at-the-stem-cell-institute.The Cambridge Stem Cell Institute is a world-leading centre for stem cell research, based at the University of Cambridge. Our mission is to transform the prevention, diagnosis and treatment of disease through a deep understanding of how stem Stem Cell Research Albert Einstein College of Medicine Stem cells have the ability to differentiate into any type of cell and offer great potential for treating conditions ranging from physical trauma to degenerative diseases and illnesses caused by genetics. Einstein is dedicated to stem cell research and regenerative medicine as well as studying the bioethics of that research. Einstein opened an NIH-supported Center for Human Embryonic Stem Cell Research in 2005, one of the first such centers in the U.S., and the Institute for Stem Cell Biology and Regenerative Medicine in 2008. In addition, stem cell and related research have been ongoing within the multidisciplinary Einstein Centers of Liver Diseases, Cancer, HIV/AIDS, Diabetes, Cardiovascular Diseases, and Developmental Disabilities. Stem Cell Debate Samantha Sequeira Biomedical engineering podcast

URL copied to clipboard!